Cobra Biologics Ltd.

https://www.cobrabio.com

Cobra Biologics is a leading international contract development and manufacturing organisation (CDMO) of biologics and pharmaceuticals for clinical and commercial supply. Cobra has three GMP approved facilities, each with expertise tailored to serving our customers around the world. We offer a broad range of integrated and stand-alone contract services, stretching from cell line and process development through to fill and finish for the supply of products for clinical trials and the commercial market. We take pride in manufacturing excellence and being a trusted provider, delivering what we promise and helping our customers to develop medicines for the benefit of patients. Cobra supplies manufacturing solutions to the pharmaceutical industry covering antibodies, recombinant proteins, viral vectors, DNA, microbiota vaccines and therapeutics as well as biologics and small molecule API lyophilisation and fill finish. *

	Start	2012-09-04 existent
	Group	Charles River (Group)
	Industry	contract manufacturing (biologicals)
	Person	Coleman, Peter (RoslinCT 202208– CEO joined 3/22 before Cobra Biologics 201106 CEO– before RecipharmCobra Biologics)

	Region	Keele, Staffordshire
	Country	United Kingdom (GB)
	Street	Stephenson Building Keele Science Park
	City	ST5 5SP Keele, Staffordshire
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Cobra Biologics Ltd.. (4/18/17). "Press Release: Cobra Biologics Embarks On £15m (165m SEK) Gene Therapy Manufacturing Operations Expansion". Keele & Matfors & Södertälje.

		Record changed: 2023-07-10